Publication Name	World Journal of Gastroenterology
Manuscript ID	6087
Country	Brazil

Received	2013-10-01 20:42
Peer-Review Started	2013-10-01 21:58
To Make the First Decision	2013-10-14 21:19
Return for Revision	2013-10-15 20:04
Revised	2013-11-12 18:27
Second Decision	2013-11-29 10:56
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-11-29 23:57
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-01-10 16:16
Publish the Manuscript Online	2014-02-17 14:01

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Percutaneous radiofrequency ablation for early hepatocellular carcinoma: Risk factors for survival
Manuscript Source	Invited Manuscript
All Author List	Luciana Kikuchi, Marcos Menezes, Aline L Chagas, Claudia M Tani, Regiane SSM Alencar, Marcio A Diniz, Venâncio AF Alves, Luiz Augusto Carneiro D’Albuquerque and Flair José Carrilho
Funding Agency and Grant Number	Funding Agency Grant Number Alves de Queiroz Family Fund for Research
Corresponding Author	Luciana Kikuchi, MD, São Paulo Clínicas Liver Cancer Group, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, Department of Gastroenterology, University of São Paulo School of Medicine, 255 Arnaldo Avenue, São Paulo 01246000, Brazil. lucianakikuchi@usp.br
Key Words	Hepatocellular carcinoma; Radiofrequency ablation; Overall survival; Disease-free survival
Core Tip	Radiofrequency ablation (RFA) is widely recognized as an effective therapy for early stage hepatocellular carcinoma (HCC) in patients who are not suitable candidates for surgical resection, such as those with decompensated liver function or portal hypertension. Reports from Brazil of clinical experience with RFA management of HCC are rare. This study evaluated 34 consecutive patients with early HCC treated with RFA at a single Brazilian hospital. RFA was efficacious for promoting local tumor control and positive outcome was related to preserved liver function. Careful evaluation of liver function may help to identify the best candidates for this procedure.
Publish Date	2014-02-17 14:01
Citation	Kikuchi L, Menezes M, Chagas AL, Tani CM, Alencar RSSM, Diniz MA, Alves VAF, D’Albuquerque LAC, Carrilho FJ. Percutaneous radiofrequency ablation for early hepatocellular carcinoma: Risk factors for survival. World J Gastroenterol 2014; 20(6): 1585-1593
URL	http://www.wjgnet.com/1007-9327/full/v20/i6/1585.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i6.1585

Full Article (PDF)	WJG-20-1585.pdf
Full Article (Word)	WJG-20-1585.doc
Manuscript File	6087-Review.docx
Answering Reviewers	6087-Answering reviewers.pdf
Copyright License Agreement	6087-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	Ethics_Committee_20131001193439.pdf
Non-Native Speakers of English Editing Certificate	6087-Language certificate.pdf
Peer-review Report	6087-Peer review(s).pdf
Scientific Editor Work List	6087-Scientific editor work list.doc